Corvus Pharmaceuticals Inc (CRVS) Stock Price, Quote, News & History

CRVSNASDAQ
$14.27
-0.65-4.36%
At close: Jul 16, 5:00 PM EST
$14.00
-0.27-1.89%
After Hours: 7:21 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-34.91M
Investing Cash Flow (TTM)
-156.89M
Financing Cash Flow (TTM)
226.90M
Free Cash Flow (TTM)
-35.14M
Capital Expenditure (TTM)
-229.00K
Net Change in Cash (TTM)
35.10M

Analyst Trends and Forecast

4
Jan
1
Mar
1
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$964.09M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
4.99
Earnings Yield % (TTM)
-3.85%
Earnings Yield % (FWD)
-4.59%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.86

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$40.10M
Debt to Equity
0.00
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$14.68
Close
$14.27
Volume / Avg.
1.26M / 1.58M
Day Range
$13.98 - $14.80
52 Wk Range
3.96 - 26.95
Market Cap
$1.18B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
43
Short Interest
25.44%
Days to Cover
12.38

About

Sector
Health Care
Industry
Biotechnology
Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Corvus Pharmaceuticals (CRVS) stock?

A

You can purchase shares of Corvus Pharmaceuticals (NASDAQ:CRVS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Corvus Pharmaceuticals (CRVS) competitors?

A

There are no as such competitors for Corvus Pharmaceuticals.

Q

What is the forecast, or price target, for Corvus Pharmaceuticals (CRVS) stock?

A

Corvus Pharmaceuticals has a consensus price target of $28.86.

Q

What is the current price for Corvus Pharmaceuticals (CRVS)?

A

The stock price for Corvus Pharmaceuticals (NASDAQ: CRVS) is $14 last updated July 16, 2026 at 7:21 PM EDT.

Q

Does Corvus Pharmaceuticals (CRVS) pay a dividend?

A

There are no upcoming dividends for Corvus Pharmaceuticals.

Q

When is Corvus Pharmaceuticals (NASDAQ:CRVS) reporting earnings?

A

Corvus Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Corvus Pharmaceuticals (CRVS) going to split?

A

There is no upcoming split for Corvus Pharmaceuticals.

Q

What sector and industry does Corvus Pharmaceuticals (CRVS) operate in?

A

Corvus Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.